Moreover, the study of Carter et al. fount that the kinase FAK within the focal adhesion pathway regulated leukemia-stromal interactions and supported leukemia cell survival, thus could be a potential therapeutic target in AML [31]. The gene discussed is PTK2; the disease is leukemia.